≥99% HPLCPre-filled pen

5-Amino-1MQ

Name: 5-Amino-1MQ
Brand: Dripfy
Availability: InStock

What it is?

5-Amino-1MQ is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT) and sits within the metabolic-enzyme and NAD+ salvage research family. It is an early-research compound investigated for adipocyte metabolism and NAD+-related longevity pathways.

Dripfy Advantage

NNMT inhibition: designed to reduce the activity of nicotinamide N-methyltransferase in adipose tissue
NAD+ salvage: linked to preserving intracellular nicotinamide for the NAD+ salvage pathway
Adipocyte metabolism: studied for effects on fat-cell energy handling
Longevity signalling: positioned within NAD+/sirtuin-adjacent research

Research & Investigational Focus

Metabolism: investigated in early research for adipocyte metabolism and energy expenditure
NAD+ biology: studied for NAD+ salvage-pathway support
Ageing pathways: explored within longevity and metabolic-ageing research

Composition & Formulation

Format: Pre-filled pen
Purity: ≥99% by HPLC/MS
Supervision: Physician-directed use only

€784

Order by email

Submit an enquiry and we arrange the consultation, physician review and shipping. Physician recommendation required; not medical advice.

Purity: ≥99%
Form: Pre-filled pen
Download Certificate of Analysis: Certificate of Analysis available on request

Important medical notice

A physician recommendation is mandatory before use.
The information on this website is educational only and is not medical advice, diagnosis, or treatment.
Always consult a qualified physician before starting any peptide.
Dosing is individualised and determined by your treating physician.

Peptide Practice Guide

Each card summarises what the peptide is studied for and its evidence strength. It is not a recommendation. Dosing and suitability are decided by your physician.

5-Amino-1MQ

NNMT inhibitor (small molecule; investigational) · Pre-filled pen

D· Preliminary evidence

5-Amino-1MQ is understood to inhibit NNMT, the enzyme that methylates nicotinamide. By reducing this methylation it is thought to preserve nicotinamide for NAD+ regeneration and to shift adipocyte energy metabolism. These effects are described mainly in cell and animal models, and human evidence is currently limited.

Studied use areas

Investigated in early research for adipocyte (fat-cell) metabolism
Studied for NAD+ salvage-pathway and cellular-energy signalling
Explored within metabolic-ageing and longevity research

Safety & status

Investigational; human safety and efficacy data are very limited
Long-term effects of NNMT inhibition in humans are not established
Use only under physician supervision; not for use in pregnancy or breastfeeding

⚕ Clinical note: 5-Amino-1MQ is an investigational, early-research compound without validated human outcomes; any consideration is physician-directed only, and nothing here is medical advice or a dosing guide.

Evidence: Grade D — investigational; limited human data, mainly preclinical · References: Kraus et al., Nature 2014; Neelakantan et al., Biochemical Pharmacology 2018; Pissios, Trends in Endocrinology & Metabolism 2017